NDC 68084-862-95 - Doxazosin
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 68084-862
- Requested NDC
- 68084-862-95
- Package NDCs from labels
- 68084-862-95, 68084-862-25, 68084-862-11, 68084-862-01
- Manufacturer
- American Health Packaging
- Effective date
- 2025-09-17
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Doxazosin - American Health Packaging | American Health Packaging | 2025-09-17 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 68084-862-01 | Doxazosin | 100 in 1 BOX, UNIT-DOSE | TABLET | 100 | 9 | |
| 68084-862-11 | Doxazosin | 1 in 1 BLISTER PACK | TABLET | 1 | 9 | |
| 68084-862-25 | Doxazosin | 30 in 1 BOX, UNIT-DOSE | TABLET | 30 | 9 | |
| 68084-862-95 | Doxazosin | 1 in 1 BLISTER PACK | TABLET | 1 | 9 |
DailyMed Dashboard NDC Coverage#
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 68084-862-01 | EA - Each | 68084-862 | b1397f3f-b113-45bf-9bea-0cd4c0bcd693 | 1 | 2020-07-13 |
| 68084-862-11 | EA - Each | 68084-862 | 2bcd84c9-feb5-421b-901d-aaab8fbcce7a | 1 | 2014-11-05 |
| 68084-862-21 | EA - Each | 68084-862 | db144491-a035-4575-b589-85647f381654 | 1 | 2014-11-05 |
| 68084-862-25 | EA - Each | 68084-862 | f320eb12-5600-4012-8063-1cceef548ad8 | 1 | 2016-03-04 |
| 68084-862-95 | EA - Each | 68084-862 | 6b831af3-16a1-41a7-82bf-bbe311879b86 | 1 | 2016-03-04 |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| DOXAZOSIN MESYLATE | ACTIVE INGREDIENT | 86P6PQK0MU | DOXAZOSIN TABLET [AMERICAN HEALTH PACKAGING] | 1 | |
| DOXAZOSIN | ACTIVE MOIETY | NW1291F1W8 | DOXAZOSIN TABLET [AMERICAN HEALTH PACKAGING] | 1 | |
| CELLULOSE, MICROCRYSTALLINE | INACTIVE INGREDIENT | OP1R32D61U | DOXAZOSIN TABLET [AMERICAN HEALTH PACKAGING] | 1 | |
| CROSCARMELLOSE SODIUM | INACTIVE INGREDIENT | M28OL1HH48 | DOXAZOSIN TABLET [AMERICAN HEALTH PACKAGING] | 1 | |
| LACTOSE MONOHYDRATE | INACTIVE INGREDIENT | EWQ57Q8I5X | DOXAZOSIN TABLET [AMERICAN HEALTH PACKAGING] | 1 | |
| MAGNESIUM STEARATE | INACTIVE INGREDIENT | 70097M6I30 | DOXAZOSIN TABLET [AMERICAN HEALTH PACKAGING] | 1 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Doxazosin | DOXAZOSIN | NuCare Pharmaceuticals, Inc. | 40e47e75-6a47-323b-e054-00144ff8d46c | 2024-08-14 | Warnings, Adverse reactions | 197627 86P6PQK0MU |
| Doxazosin | DOXAZOSIN | NuCare Pharmaceuticals, Inc. | 505d3c4c-5506-72cc-e054-00144ff88e88 | 2024-07-09 | Warnings, Adverse reactions | ANDA075580 197627 86P6PQK0MU |
| Doxazosin | DOXAZOSIN | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | 7991373e-8a62-47f9-b4fb-90573485af4e | 2024-07-04 | Warnings, Adverse reactions | 197625 197626 197627 86P6PQK0MU |
| Doxazosin | DOXAZOSIN | Rising Pharma Holdings, Inc. | 508b908e-8d80-422e-8ec0-2081185f4c95 | 2024-06-19 | Warnings, Adverse reactions | 197625 197626 197627 86P6PQK0MU |
| Doxazosin | DOXAZOSIN | A-S Medication Solutions | 4034fb6d-f55d-4df0-b500-d6a413591f6e | 2024-06-12 | Warnings, Adverse reactions | 197625 197626 197627 86P6PQK0MU |
| Doxazosin | DOXAZOSIN | A-S Medication Solutions | 9f67fa58-f623-4145-9e2c-98feee7ca45f | 2024-06-10 | Warnings, Adverse reactions | 197626 86P6PQK0MU |
| Doxazosin | DOXAZOSIN | A-S Medication Solutions | 46b01b1d-c48a-4c36-bf3c-bba98066166c | 2024-06-10 | Warnings, Adverse reactions | 197627 86P6PQK0MU |
| Doxazosin | DOXAZOSIN | NuCare Pharmaceuticals,Inc. | 64a243e6-7056-115d-e053-2a91aa0a510f | 2024-06-06 | Warnings, Adverse reactions | 197625 86P6PQK0MU |
| Doxazosin | DOXAZOSIN | NuCare Pharmaceuticals,Inc. | 64a19cb1-79fc-8b0b-e053-2a91aa0aaa94 | 2024-06-06 | Warnings, Adverse reactions | 197626 86P6PQK0MU |
| Doxazosin | DOXAZOSIN | Proficient Rx LP | 1d8ff659-8129-4dca-9e8f-13b97240d1e1 | 2024-06-01 | Warnings, Adverse reactions | ANDA075580 197627 86P6PQK0MU |
| Doxazosin | DOXAZOSIN | Aphena Pharma Solutions - Tennessee, LLC | 187bc51b-7a3a-5910-e063-6294a90aa888 | 2024-05-15 | Warnings, Adverse reactions | 86P6PQK0MU |
| Doxazosin | DOXAZOSIN | Bryant Ranch Prepack | 6fbb9ca2-e8ca-45c7-a178-b4c8dd7a9a1f | 2024-04-29 | Warnings, Adverse reactions | 197626 86P6PQK0MU |
| Doxazosin mesylate | DOXAZOSIN MESYLATE | Mylan Pharmaceuticals Inc. | 2e524986-7903-416f-b2b8-d27295103e75 | 2024-03-11 | Warnings, Adverse reactions | 197625 197626 197627 86P6PQK0MU |
| Doxazosin | DOXAZOSIN MESYLATE | Aphena Pharma Solutions - Tennessee, LLC | 0d9df8e9-f823-4ff8-a5fe-0309dd132b04 | 2024-02-06 | Warnings, Adverse reactions | 197627 86P6PQK0MU |
| Doxazosin Mesylate | DOXAZOSIN MESYLATE | Unichem Pharmaceuticals (USA), Inc. | 44bfe5d7-a56a-46f1-8ef3-ad386ab35f0f | 2024-01-23 | Warnings, Adverse reactions | 197625 197626 197627 86P6PQK0MU |
| Cardura | DOXAZOSIN | Viatris Specialty LLC | 5e1f5e49-2da1-43ab-9795-228a8bcc5a82 | 2023-10-15 | Warnings, Adverse reactions | 197625 197626 197627 86P6PQK0MU |
| Doxazosin | DOXAZOSIN | Zydus Pharmaceuticals USA Inc. | e4758bf9-b9d4-4268-beb8-0d7e06890895 | 2023-09-16 | Warnings, Adverse reactions | 197625 197626 197627 86P6PQK0MU |
| Doxazosin mesylate | DOXAZOSIN MESYLATE | Chartwell RX, LLC | a7f589b0-eebb-48cb-912f-a4bd956e4dcb | 2023-06-09 | Warnings, Adverse reactions | 197625 197626 197627 86P6PQK0MU |
| Cardura XL | DOXAZOSIN MESYLATE | Viatris Specialty LLC | 355bcdce-0481-48ba-8ebd-2009106aaf77 | 2023-05-15 | Warnings, Adverse reactions | 86P6PQK0MU |
| Doxazosin | DOXAZOSIN | Proficient Rx LP | 8de7d5ee-7f9d-447a-af76-7a7fbf3eb33d | 2022-08-01 | Warnings, Adverse reactions | 197627 86P6PQK0MU |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.